6535 RESULTS
Sort By:
Douglas Kerr and colleagues at Johns Hopkins (Abstract 209.13) reported success in using neural stem cells to restore function in an animal model of spinal motor atrophy (SMA). In SMA, the ventral horn motor neurons...
Parkinson's disease is one of the most common neurodegenerative diseases, affecting about one percent of all people over the age of 65. It is characterized by rigidity, bradykinesia and tremors, which are caused by the progressive degeneration of dopamine-containing neurons...
A central problem in Alzheimer's disease is to understand how Aβ affects the brain's biology, and how it contributes to neurodegeneration. A diverse array of mechanisms have been proposed...
It is not only the abnormal product of amyloid precursor protein—the amyloid-β peptide—that interests researchers of Alzheimer's disease. There is also a line of inquiry that hopes to find clues to the disease in the normal function of amyloid precursor protein...
William Harvey Research Conference: The Role of COX-2 Inhibitors in Inflammatory and Other Diseases William Harvey Research Conference
A new study published today in Science finds that GDNF genes delivered by a lentiviral vector reversed functional deficits and prevented neurodegeneration in a primate model...
The 15 invited conference speakers reported their most current findings on cyxlooxygenase (COX-1 and COX-2) inhibitor research including the latest technical developments concerning the relevance of COX-2...
Gene Therapy Rescues Neurons in Parkinson's Model American Neurological Association: 2000 Annual Meeting
Neural stem cells have been heralded as a potential therapy to rebuild injured and diseased brain tissue, but to achieve that vision, researchers must decipher the molecular signals that direct the cells to migrate through the brain...
A two-gene therapy strategy prevents the death of dopamine neurons and preserves their function, according to a study by Jorg Schulz and colleagues at the University of Tubingen in Germany...
Researchers announced a step forward in the rational design of drugs to inhibit β-secretase with the publication in tomorrow's Science of the crystal structure of the enzyme locked in a complex with a novel inhibitor...
A nasally administered vaccine of amyloid-β (Aβ) can significantly reduce the Aβ burden in the brains of transgenic mouse models of Alzheimer's disease, report Howard Weiner, Dennis Selkoe, and their Harvard colleagues...
A feat that has eluded researchers for some time—the creation of an animal model of human mitochondrial DNA (mtDNA) diseases—has finally been accomplished. Japanese researchers report that they have created mutant mice with a large-scale mtDNA deletion...
The prion protein, so interesting to researchers of neurodegenerative disease for its novel capacity to cause disease through a change of conformation—and to transmit disease to other cells and organisms through its altered conformation—may have...
Through a nice piece of protein chemistry work, Yu and colleagues from Peter St. George Hyslop’s laboratory have shown that a novel protein, named nicastrin, associates with preseniln 1 and presenilin 2...
No filters selected
